Becton, Dickinson and Company (BDX) Bank of America Securities Health Care Conference - (Transcript)

Company Overview - Becton, Dickinson and Company is a nearly $22 billion company that has undergone significant transformations, including two large acquisitions of CareFusion and Bard [4]. Recent Developments - The company has successfully brought the Alaris product back to market and achieved a run rate, alongside making strategic portfolio adjustments such as the divestiture of its diabetes segment and the acquisition of the Edwards Critical Care business and Parata [3]. Financial Performance - Despite improvements in operational margins and strategic initiatives, the company's stock has declined, attributed to perceptions of slowed revenue growth [3].